معرفی
Prof. Gert Folkerts is a Professor in Pharmacology at Utrecht University's Department of Pharmaceutical Sciences (Beta Faculty). His career began at Utrecht University in 1981, spanning roles across the Medical, Veterinary, and Pharmacy Faculties. He holds editorial roles in the European Journal of Pharmacology and led the contract research firm Curax BV. His research focuses on use-inspired immunopharmacology of chronic inflammatory diseases and respiratory/gastrointestinal system interactions, with emphasis on gut-lung axis mechanisms, anti-microbial resistance, and translational drug/food concepts.
Key career highlights include Vice-chairmanship of the Horizon ITN-funded 'Stop Spreading Bad Bugs' consortium and recognition as one of Elsevier’s top 2% global researchers (2022). His work combines in vitro/in vivo models to explore bacterial infections, COPD, asthma, and dietary interventions (e.g., oligosaccharides) for immune modulation. Notable collaborations include the Netherlands Respiratory Society and the Carbohydrate Competence Centre.
Research trends show a strong focus on microbiota interactions, respiratory immune responses, and translational applications of nutritional components. Recent articles emphasize synbiotic therapies for pollution-related asthma and novel oligosaccharide treatments for bacterial infections. Awards include an H-Factor of 62, reflecting impactful contributions to immunology and pharmacology.
His academic leadership includes editorships, contract research management, and scientific advisory roles (e.g., Dutch Lung Fund). Ongoing projects involve gut-lung axis mechanisms in COPD, food allergy prevention via human milk oligosaccharides, and microbiome-driven therapies.